Lee Scott Golden is VP at PTC THERAPEUTICS, INC. (PTCT). They have made 10 open-market trades across 1 company since 2024, most recently 2026-04-02.
CIK 0001686217
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTCT | 79,115 | $4.7M |
Shares reported on the most recent Form 4, priced at the 2026-04-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTCT | SELL | 2026-04-02 | 2026-04-06 | $67.99 | $56K | +4.0% | -3.4% | +24.0% |
| PTCT | SELL · 10b5-1 | 2026-03-05 | 2026-03-09 | $63.38 | $634K | -2.0% | +4.2% | +3.6% |
| PTCT | SELL | 2026-02-18 | 2026-02-20 | $69.36 | $172K | -8.1% | -5.1% | -0.3% |
| PTCT | SELL | 2026-01-08 | 2026-01-12 | $76.45 | $66K | -1.9% | -7.6% | -8.2% |
| PTCT | SELL | 2026-01-06 | 2026-01-08 | $77.12 | $153K | -2.9% | -4.7% | -8.4% |
| PTCT | SELL | 2025-04-02 | 2025-04-04 | $46.95 | $42K | +11.1% | -2.7% | +17.4% |
| PTCT | SELL | 2025-02-19 | 2025-02-21 | $50.11 | $88K | +2.9% | +13.0% | -9.8% |
| PTCT | SELL | 2025-01-07 | 2025-01-10 | $44.84 | $90K | +6.2% | +14.5% | -7.4% |
| PTCT | SELL | 2024-05-07 | 2024-05-08 | $32.82 | $6K | +28.8% | +17.3% | +3.1% |
| PTCT | SELL | 2024-04-02 | 2024-04-04 | $28.37 | $15K | -7.4% | +20.7% | +13.5% |
| PTCT | SELL | 2024-01-08 | 2024-01-10 | $28.87 | $58K | -1.7% | -10.3% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.